**Core Concept**
Thrombotic Thrombocytopenic Purpura (TTP) is a rare blood disorder characterized by the formation of blood clots in small blood vessels throughout the body, leading to low platelet count. The underlying pharmacological principle being tested involves the management of TTP using various therapeutic agents.

**Why the Correct Answer is Right**
The correct answer is not provided, however, typical treatments for TTP include plasma exchange, corticosteroids, and certain medications that inhibit the formation of blood clots.

**Why Each Wrong Option is Incorrect**
**Option A:** Without the specific option, it's challenging to provide a detailed explanation. However, common treatments for TTP do not typically include anticoagulants as a first-line treatment due to the risk of exacerbating the condition.
**Option B:** Similarly, without the specific option, it's difficult to provide a detailed explanation.
**Option C:** and **Option D:** also require specific details to provide accurate explanations.

**Clinical Pearl / High-Yield Fact**
A key point to remember in the treatment of TTP is the importance of prompt plasma exchange to remove autoantibodies and replace the deficient enzyme ADAMTS13, which is often deficient in patients with TTP.

**Correct Answer:** Not provided in the query.